During the week of June 15, 2026, FDA issued 25 warning letters to telehealth companies over alleged false or misleading promotional claims about compounded GLP-1 productsclaims the agency views as violating the Federal Food, Drug, and Cosmetic Acts (FDCA) misbranding provisions, including Sections 502(a) and 502(n)
What to look for beyond price The cheapest option is not always the best value
Supplements and Nutrients to Consider Alongside Retatrutide Dietary and Lifestyle Recommendations While Taking Retatrutide Medications That May Interact With Retatrutide What to Avoid When Taking Retatrutide Guidance From Your GP or Specialist Before Starting Retatrutide Scientific References Frequently Asked Questions What Is Retatrutide and How Does It Work
These changes can be subtle at first but are often the earliest indication that tirzepatide is starting to work
Consequently, 39 articles were included in the systematic review and dose-response network meta-analysis [11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49]